Literature DB >> 19064632

Association of Bacillus anthracis capsule with lethal toxin during experimental infection.

J W Ezzell1, T G Abshire, R Panchal, D Chabot, S Bavari, E K Leffel, B Purcell, A M Friedlander, W J Ribot.   

Abstract

Bacillus anthracis lethal toxin (LT) was characterized in plasma from infected African Green monkeys, rabbits, and guinea pigs. In all cases, during the terminal phase of infection only the protease-activated 63-kDa form of protective antigen (PA(63)) and the residual 20-kDa fragment (PA(20)) were detected in the plasma. No uncut PA with a molecular mass of 83 kDa was detected in plasma from toxemic animals during the terminal stage of infection. PA(63) was largely associated with lethal factor (LF), forming LT. Characterization of LT by Western blotting, capture enzyme-linked immunosorbent assay, and size exclusion chromatography revealed that the antiphagocytic poly-gamma-d-glutamic acid (gamma-DPGA) capsule released from B. anthracis bacilli was associated with LT in animal blood in variable amounts. While the nature of this in vivo association is not understood, we were able to determine that a portion of these LT/gamma-DPGA complexes retained LF protease activity. Our findings suggest that the in vivo LT complexes differ from in vitro-produced LT and that including gamma-DPGA when examining the effects of LT on specific immune cells in vitro may reveal novel and important roles for gamma-DPGA in anthrax pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19064632      PMCID: PMC2632019          DOI: 10.1128/IAI.00764-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin.

Authors:  S F Little; S H Leppla; A M Friedlander
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.

Authors:  B E Ivins; S L Welkos; G B Knudson; S F Little
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

3.  Serum protease cleavage of Bacillus anthracis protective antigen.

Authors:  J W Ezzell; T G Abshire
Journal:  J Gen Microbiol       Date:  1992-03

4.  Identification of a novel gene, dep, associated with depolymerization of the capsular polymer in Bacillus anthracis.

Authors:  I Uchida; S Makino; C Sasakawa; M Yoshikawa; C Sugimoto; N Terakado
Journal:  Mol Microbiol       Date:  1993-08       Impact factor: 3.501

5.  On the role of macrophages in anthrax.

Authors:  P C Hanna; D Acosta; R J Collier
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

6.  Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin.

Authors:  K R Klimpel; S S Molloy; G Thomas; S H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

7.  Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells.

Authors:  V Escuyer; R J Collier
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

8.  Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis.

Authors:  S L Welkos; J R Lowe; F Eden-McCutchan; M Vodkin; S H Leppla; J J Schmidt
Journal:  Gene       Date:  1988-09-30       Impact factor: 3.688

9.  Molecular cloning and expression of the Bacillus anthracis edema factor toxin gene: a calmodulin-dependent adenylate cyclase.

Authors:  M T Tippetts; D L Robertson
Journal:  J Bacteriol       Date:  1988-05       Impact factor: 3.490

10.  Purification and physical analysis of Bacillus anthracis plasmids pXO1 and pXO2.

Authors:  R L Kaspar; D L Robertson
Journal:  Biochem Biophys Res Commun       Date:  1987-12-16       Impact factor: 3.575

View more
  19 in total

Review 1.  New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.

Authors:  Annabel Guichard; Victor Nizet; Ethan Bier
Journal:  Microbes Infect       Date:  2011-09-08       Impact factor: 2.700

2.  Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule.

Authors:  Zhaochun Chen; Rachel Schneerson; Julie Lovchik; C Rick Lyons; Huaying Zhao; Zhongdong Dai; Joanna Kubler-Kielb; Stephen H Leppla; Robert H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

3.  Role of the protective antigen octamer in the molecular mechanism of anthrax lethal toxin stabilization in plasma.

Authors:  Alexander F Kintzer; Harry J Sterling; Iok I Tang; Ali Abdul-Gader; Andrew J Miles; B A Wallace; Evan R Williams; Bryan A Krantz
Journal:  J Mol Biol       Date:  2010-04-28       Impact factor: 5.469

Review 4.  The Bacillus cereus Group: Bacillus Species with Pathogenic Potential.

Authors:  Monika Ehling-Schulz; Didier Lereclus; Theresa M Koehler
Journal:  Microbiol Spectr       Date:  2019-05

5.  Human Innate Immune Cells Respond Differentially to Poly-γ-Glutamic Acid Polymers from Bacillus anthracis and Nonpathogenic Bacillus Species.

Authors:  Tanya M Jelacic; Wilson J Ribot; Jennifer Chua; Anne E Boyer; Adrian R Woolfitt; John R Barr; Arthur M Friedlander
Journal:  J Immunol       Date:  2020-01-13       Impact factor: 5.422

6.  The poly-γ-D-glutamic acid capsule of Bacillus anthracis enhances lethal toxin activity.

Authors:  Jeyoun Jang; Minhui Cho; Jeong-Hoon Chun; Min-Hee Cho; Jungchan Park; Hee-Bok Oh; Cheon-Kwon Yoo; Gi-eun Rhie
Journal:  Infect Immun       Date:  2011-06-20       Impact factor: 3.441

7.  Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax.

Authors:  Julie A Lovchik; Melissa Drysdale; Theresa M Koehler; Julie A Hutt; C Rick Lyons
Journal:  Infect Immun       Date:  2012-04-23       Impact factor: 3.441

8.  The protective antigen component of anthrax toxin forms functional octameric complexes.

Authors:  Alexander F Kintzer; Katie L Thoren; Harry J Sterling; Ken C Dong; Geoffrey K Feld; Iok I Tang; Teri T Zhang; Evan R Williams; James M Berger; Bryan A Krantz
Journal:  J Mol Biol       Date:  2009-07-20       Impact factor: 5.469

9.  Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With Ciprofloxacin.

Authors:  Nicholas J Vietri; Steven A Tobery; Donald J Chabot; Susham Ingavale; Brandon C Somerville; Jeremy A Miller; Chris W Schellhase; Nancy A Twenhafel; David P Fetterer; Christopher K Cote; Christopher P Klimko; Anne E Boyer; Adrian R Woolfitt; John R Barr; Mary E Wright; Arthur M Friedlander
Journal:  J Infect Dis       Date:  2021-02-03       Impact factor: 5.226

10.  Anthrax toxin protective antigen integrates poly-γ-D-glutamate and pH signals to sense the optimal environment for channel formation.

Authors:  Alexander F Kintzer; Iok I Tang; Adam K Schawel; Michael J Brown; Bryan A Krantz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.